A U.S. senator is asking the FDA how it will enforce regulations on pharmaceutical advertising after it let go of numerous ...

HHS Secretary Robert F. Kennedy Jr. announced that he has unilaterally struck the recommendation that healthy children and ...

The custom-built gene editing treatment for 6-month-old KJ Muldoon could not have come at a more welcome or jarring time for ...

Across New England and the country, thousands of budding scientists have awoken to a stark new reality, following funding ...

A patient in a Rocket Pharmaceuticals gene therapy trial for a rare heart condition has died, the company said.

In today's D.C. Diagnosis newsletter, layoffs hit the National Academies, and a look at what's already been lost from firings ...

Last week, I was flipping through the newly filed financial documents of AdventHealth, and the numbers hit me like an ...

Digital physical therapy company Hinge Health went public last week, raising $437 million and ending an IPO drought for ...

Biogen and City Therapeutics, a privately held developer of RNA-based “trigger molecules,” announced a partnership to develop ...

As a public health official, Jay K. Varma has handled putative anthrax attacks. He says an AI-simulated bioterror attack ...

Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...

The National Academies of Sciences, Engineering, and Medicine is preparing for a major reorganization as it tries to reduce ...